Skip to content

Study of the Mupirocin effect on Nasal Staph aureus decolonization and prevention of Intensive Care Unit infection: A Clinical Trial

Study of the Mupirocin effect on Nasal Staph aureus decolonization and prevention of Intensive Care Unit infection: A Clinical Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013110915327N1
Enrollment
170
Registered
2014-01-31
Start date
2013-11-26
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nosocomial Infection with staphylococcus aureus. Staphylococcal infection, unspecified site

Interventions

Intervention 1: Intervention group: persons who have positive cultivation using mupirosin2% made in Caspian company twice in day (each 12 hours) during 5 days. Intervention 2: Control group1: Persons
Treatment - Drugs
Intervention group: persons who have positive cultivation using mupirosin2% made in Caspian company twice in day (each 12 hours) during 5 days
Control group1: Persons who have negative cultivation and are followed up
Control group 2: Persons who have positive cultivation but don't get any treatment and are followed up

Sponsors

Vice Chancellor for research of Arak University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients admitted to Intensive Care Unit ; Age 16 years and more. Exclusion criteria: incomplete treatment period

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nasal carrierity. Timepoint: 48 hours after admission. Method of measurement: Positive Culture.;Staphylococcus aureus infection. Timepoint: During the time of hospitalization and 10 days after discharge. Method of measurement: Positive Culture.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Zeynab Saeedinejad

Arak University Of Medical Sciences

dr.saeedinejad@arakmu.ac.ir+98 86 3224 1411

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026